JY
PLRX icon

Jeff Yass’s Pliant Therapeutics PLRX Stock Holding History

Jeff Yass’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,700
Closed -$28.6K – 14271
2026
Q1 		$28.6K Sell
22,700
-92,600
-80% -$117K ﹤0.01% 12778
2025
Q4 		$141K Buy
115,300
+58,800
+104% +$88.3K ﹤0.01% 11225
2025
Q3 		$83.6K Sell
56,500
-12,100
-18% -$18.5K ﹤0.01% 11660
2025
Q2 		$79.6K Sell
68,600
-35,300
-34% -$49.9K ﹤0.01% 11914
2025
Q1 		$140K Buy
103,900
+30,200
+41% +$183K ﹤0.01% 11282
2024
Q4 		$971K Buy
73,700
+44,600
+153% +$609K ﹤0.01% 7023
2024
Q3 		$326K Sell
29,100
-46,000
-61% -$576K ﹤0.01% 9418
2024
Q2 		$807K Sell
75,100
-6,700
-8% -$86.4K ﹤0.01% 7096
2024
Q1 		$1.22M Buy
81,800
+69,500
+565% +$1.15M ﹤0.01% 6424
2023
Q4 		$223K Sell
12,300
-4,500
-27% -$68.4K ﹤0.01% 10454
2023
Q3 		$291K Sell
16,800
-131,500
-89% -$2.28M ﹤0.01% 9408
2023
Q2 		$2.69M Buy
148,300
+36,200
+32% +$857K ﹤0.01% 4566
2023
Q1 		$2.98M Buy
112,100
+28,200
+34% +$803K ﹤0.01% 4343
2022
Q4 		$1.62M Sell
83,900
-12,700
-13% -$265K ﹤0.01% 5111
2022
Q3 		$2.02M Buy
96,600
+41,600
+76% +$796K ﹤0.01% 4914
2022
Q2 		$441K Buy
+55,000
New +$352K ﹤0.01% 8582
2022
Q1 		– Sell
-20,600
Closed -$278K – 13745
2021
Q4 		$278K Buy
+20,600
New +$327K ﹤0.01% 10671

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Jeff Yass's PLRX Position: Q2 2026 in Review

Jeff Yass reduced its Pliant Therapeutics (PLRX) stake by 71% in Q2 2026, selling an estimated $45.6K and leaving 15,480 shares worth $17.6K. The position accounts for ﹤0.01% of the portfolio, ranked #13065.

Jeff Yass first reported a position in PLRX in Q3 2020 and has held it in 23 quarters since. The position peaked at $15.9M in Q1 2023. 86 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • Jeff Yass held 15,480 shares of Pliant Therapeutics worth $17.6K as of Q2 2026.
  • Jeff Yass sold 37,476 Pliant Therapeutics shares in Q2 2026, an estimated $45.6K.
  • Pliant Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #13065 holding.
  • Jeff Yass first reported a position in Pliant Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Jeff Yass's Pliant Therapeutics position peaked at $15.9M in Q1 2023.
  • 86 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.